These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 38221591)
41. Association between self-reported snoring and metabolic-associated fatty liver disease: A cross-sectional analysis of the NHANES 2017-2018. Wang Y; Shen R; Ge J Sleep Med; 2023 Jan; 101():414-420. PubMed ID: 36516525 [TBL] [Abstract][Full Text] [Related]
42. Association of coffee intake with bone mineral density: a Mendelian randomization study. Ye Y; Zhong R; Xiong XM; Wang CE Front Endocrinol (Lausanne); 2024; 15():1328748. PubMed ID: 38572474 [TBL] [Abstract][Full Text] [Related]
43. Depression and Osteoporosis: A Mendelian Randomization Study. He B; Lyu Q; Yin L; Zhang M; Quan Z; Ou Y Calcif Tissue Int; 2021 Dec; 109(6):675-684. PubMed ID: 34259888 [TBL] [Abstract][Full Text] [Related]
44. Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease. Kim G; Kim KJ; Rhee Y; Lim SK PLoS One; 2017; 12(7):e0182202. PubMed ID: 28759632 [TBL] [Abstract][Full Text] [Related]
45. Investigating the causal relationship between ankylosing spondylitis and osteoporosis in the European population: a bidirectional Mendelian randomization study. Mei J; Hu H; Ding H; Huang Y; Zhang W; Chen X; Fang X Front Immunol; 2023; 14():1163258. PubMed ID: 37359532 [TBL] [Abstract][Full Text] [Related]
46. Inferring causal effects of homocysteine and B-vitamin concentrations on bone mineral density and fractures: Mendelian randomization analyses. Fu L; Wang Y; Hu YQ Front Endocrinol (Lausanne); 2022; 13():1037546. PubMed ID: 36518252 [TBL] [Abstract][Full Text] [Related]
47. Tumor necrosis factor mediates the impact of PM Li M; Shi P; Yang H; Tong S; Qiu N; Yao F; Du Y; Xi S; Wang F Ecotoxicol Environ Saf; 2024 Jan; 270():115896. PubMed ID: 38184974 [TBL] [Abstract][Full Text] [Related]
48. The Impact of Non-alcohol Fatty Liver Disease on Bone Mineral Density is Mediated by Sclerostin by Mendelian Randomization Study. Liu Y; Yuan M; He J; Cai L; Leng A Calcif Tissue Int; 2024 May; 114(5):502-512. PubMed ID: 38555554 [TBL] [Abstract][Full Text] [Related]
49. Effects of FGF21 overexpression in osteoporosis and bone mineral density: a two-sample, mediating Mendelian analysis. Liu J; Jiang J; Li Y; Chen Q; Yang T; Lei Y; He Z; Wang X; Na Q; Lao C; Luo X; Yang L; Yang Z Front Endocrinol (Lausanne); 2024; 15():1439255. PubMed ID: 39296716 [TBL] [Abstract][Full Text] [Related]
50. Circulating Serum 25-Hydroxyvitamin D Levels and Bone Mineral Density: Mendelian Randomization Study. Larsson SC; Melhus H; Michaƫlsson K J Bone Miner Res; 2018 May; 33(5):840-844. PubMed ID: 29338102 [TBL] [Abstract][Full Text] [Related]
51. Association between dietary intake of carotenoids and metabolic dysfunction-associated fatty liver disease in US adults: National Health and Nutrition Examination Survey 2017-March 2020. Yu J; Guo P Public Health Nutr; 2024 Sep; 27(1):e168. PubMed ID: 39313756 [TBL] [Abstract][Full Text] [Related]
52. Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization study. Zhao J; Zeng J; Zhu C; Li X; Liu D; Zhang J; Li F; Targher G; Fan JG BMC Med; 2023 Nov; 21(1):469. PubMed ID: 38017422 [TBL] [Abstract][Full Text] [Related]
53. Mid-upper arm circumference is associated with liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease: A population based observational study. Wang X; Li X; Jin R; Yang J; Huang R; Wei L; Liu F; Rao H Hepatol Commun; 2022 Sep; 6(9):2262-2272. PubMed ID: 35560825 [TBL] [Abstract][Full Text] [Related]
54. [Applied research of ultrasound attenuation parameter in the diagnosis of metabolic dysfunction-associated fatty liver disease]. Hou MM; Yuan XW; Wang YQ; Zhang Y; Zhang SY; Yu SH; Nan YM Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):290-296. PubMed ID: 35462485 [No Abstract] [Full Text] [Related]
55. Anti-inflammatory diet reduces risk of metabolic dysfunction-associated fatty liver disease among US adults: a nationwide survey. Hu W; Luo L; Li M; Xiong X; Huang W; Huang Y; Sun J; Ding H; Yu H Scand J Gastroenterol; 2024 Oct; 59(10):1192-1201. PubMed ID: 39215699 [TBL] [Abstract][Full Text] [Related]
56. Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003-2018. Xie Z; Aimuzi R; Si M; Qu Y; Jiang Y Front Public Health; 2023; 11():1133194. PubMed ID: 36950101 [TBL] [Abstract][Full Text] [Related]
57. Lack of causal association between heart failure and osteoporosis: a Mendelian randomization study. Chen H; Ye R; Guo X BMC Med Genomics; 2022 Nov; 15(1):232. PubMed ID: 36333784 [TBL] [Abstract][Full Text] [Related]
58. Positive effects of low LDL-C and statins on bone mineral density: an integrated epidemiological observation analysis and Mendelian randomization study. Li GH; Cheung CL; Au PC; Tan KC; Wong IC; Sham PC Int J Epidemiol; 2020 Aug; 49(4):1221-1235. PubMed ID: 31302685 [TBL] [Abstract][Full Text] [Related]
59. Circulating serum vitamin D levels and total body bone mineral density: A Mendelian randomization study. Sun JY; Zhao M; Hou Y; Zhang C; Oh J; Sun Z; Sun BL J Cell Mol Med; 2019 Mar; 23(3):2268-2271. PubMed ID: 30637964 [TBL] [Abstract][Full Text] [Related]
60. Genetically Predicted Sex Hormone-Binding Globulin and Bone Mineral Density: A Mendelian Randomization Study. Qu Z; Jiang J; Yang F; Huang J; Zhao J; Yan S Calcif Tissue Int; 2021 Mar; 108(3):281-287. PubMed ID: 33068140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]